MFSD1
Lysosomal dipeptide transporter MFSD1
Also known as: FLJ14153, MFSD1_HUMAN, Minerva, UG0581B09
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H3U5
- Gene
- MFSD1
- Ensembl
- ENSG00000118855
- Chromosome
- 3
- Canonical length
- 465 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Plasma membrane,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Enables dipeptide uniporter activity. Involved in dipeptide transmembrane transport from lysosomal lumen to cytosol. Is active in lysosomal membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
465 residues, UniProt reviewed canonical sequence.
>Q9H3U5|MFSD1
1 MEEEDEEARA LLAGGPDEAD RGAPAAPGAL PALCDPSRLA HRLLVLLLMC FLGFGSYFCY
61 DNPAALQTQV KRDMQVNTTK FMLLYAWYSW PNVVLCFFGG FLIDRVFGIR WGTIIFSCFV
121 CIGQVVFALG GIFNAFWLME FGRFVFGIGG ESLAVAQNTY AVSWFKGKEL NLVFGLQLSM
181 ARIGSTVNMN LMGWLYSKIE ALLGSAGHTT LGITLMIGGI TCILSLICAL ALAYLDQRAE
241 RILHKEQGKT GEVIKLTDVK DFSLPLWLIF IICVCYYVAV FPFIGLGKVF FTEKFGFSSQ
301 AASAINSVVY VISAPMSPVF GLLVDKTGKN IIWVLCAVAA TLVSHMMLAF TMWNPWIAMC
361 LLGLSYSLLA CALWPMVAFV VPEHQLGTAY GFMQSIQNLG LAIISIIAGM ILDSRGYLFL
421 EVFFIACVSL SLLSVVLLYL VNRAQGGNLN YSARQREEIK FSHTELocalizationUniProt · AlphaFold · HPA
Whether an antibody against MFSD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 12
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 46 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 46 nTPM
- salivary gland: 46 nTPM
- spleen: 40 nTPM
- lung: 38 nTPM
- urinary bladder: 37 nTPM
- adipose tissue: 37 nTPM
Single-cell type
- epicardial cells: 687 nCPM
- platelets: 582 nCPM
- kupffer cells: 578 nCPM
- esophageal apical cells: 427 nCPM
- macrophages: 316 nCPM
- hofbauer cells: 287 nCPM
Immune cell
- classical monocyte: 289 nTPM
- myeloid DC: 255 nTPM
- total PBMC: 252 nTPM
- eosinophil: 247 nTPM
- intermediate monocyte: 224 nTPM
- non-classical monocyte: 189 nTPM
Brain region
- choroid plexus: 79 nTPM
- cerebellum: 70 nTPM
- white matter: 65 nTPM
- pons: 62 nTPM
- medulla oblongata: 62 nTPM
- thalamus: 62 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.25
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.02
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- protein localization to lysosome
- protein stabilization
- dipeptide transmembrane transport from lysosomal lumen to cytosol
Molecular functions
- protein homodimerization activity
- dipeptide uniporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Major facilitator superfamily
- Major facilitator superfamily domain
- MFS transporter superfamily
- Major Facilitator Superfamily
- Lysosomal dipeptide transporter MFSD1
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MFSD1 as an antibody target. Whether an autoantibody or antibody against MFSD1 could matter depends on whether native MFSD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MFSD1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MFSD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...